Hiring in Life Sciences is Becoming More Difficult, Study Shows

INSIGHTS HUB



Talent Trends: Keeping Yourself Safe When Navigating the Salary Ban

2021 – The Pandemic’s Surprising Impact on Hiring in the Life Sciences
Shockwave to acquire Neovasc in $100M deal
JUVENESCENCE Appoints Dr Richard Marshall CBE as CEO
Chiesi to Buy Amryt for $1.5 Billion in Rare Disease Expansion
Novavax Names John C. Jacobs as New President & Chief Executive Officer
Baxter to Spinout $5B Kidney Care Business
ReCor Medical Names Lara Barghout President and Chief Executive Officer
Hummingbird and Synaffix agree to antibody-drug conjugate deal worth up to $150M
Gilead announces $658.5M deal with EVOQ
Minerva Surgical Names Todd Usen as President and CEO
Moderna to buy Japan-based OriCiro Genomics for US $85M
Gilgamesh Pharmaceuticals Raises $39 Million Series B to Advance Mental Health Treatments
CN Bio appoints Dr Paul Brooks as Chief Executive Officer
Synchron Raises $75M Series C Led by ARCH Venture Partners to Advance Endovascular Brain-Computer
Activ Surgical Appoints Manisha Shah-Bugaj as Chief Executive Officer
Japan's Takeda to buy Nimbus' Psoriasis Drug for as much as $6 bln
Paragon spinout Apogee Therapeutics emerges with $169 million to expand team
Karuna Therapeutics Appoints Bill Meury as President and Chief Executive Officer
Cannon is expected to put $300 into new US Subsidiary
Roche Announces Brad Moore as President and CEO of Roche Diagnostics North America
Summit bets $5B on Akeso, $500million upfront, and milestone payments of $4B for cancer therapy deal